• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

VGSCs-IN-1

CAS No. 1204296-79-6

VGSCs-IN-1 ( —— )

产品货号. M37270 CAS No. 1204296-79-6

VGSCs-IN-1 (compound 14) 是 Riluzole (HY-B0211) 的 2-哌嗪类似物,是一种人电压门控钠通道 (VGSC) 抑制剂。VGSCs-IN-1 显示出良好的 Nav1.4 阻断活性。VGSCs-IN-1 的 pKa 为 7.6,cLog P 为 2.4。VGSCs-IN-1可用于细胞兴奋性障碍研究。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2157 有现货
10MG ¥3154 有现货
25MG ¥4864 有现货
50MG ¥6417 有现货
100MG ¥8568 有现货
200MG ¥11520 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    VGSCs-IN-1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    VGSCs-IN-1 (compound 14) 是 Riluzole (HY-B0211) 的 2-哌嗪类似物,是一种人电压门控钠通道 (VGSC) 抑制剂。VGSCs-IN-1 显示出良好的 Nav1.4 阻断活性。VGSCs-IN-1 的 pKa 为 7.6,cLog P 为 2.4。VGSCs-IN-1可用于细胞兴奋性障碍研究。
  • 产品描述
    VGSCs-IN-1 (compound 14), a 2-piperazine analog of Riluzole (HY-B0211), is a human voltage-gated sodium channels (VGSCs) inhibitor. VGSCs-IN-1 shows great Nav1.4 blocking activity. VGSCs-IN-1 has a pKa of 7.6 and a cLog P of 2.4. VGSCs-IN-1 can be used for cell excitability disorders research.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Membrane Transporter/Ion Channel
  • 靶点
    Sodium Channel
  • 受体
    Sodium Channel
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1204296-79-6
  • 分子量
    303.3
  • 分子式
    C12H12F3N3OS
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    FC(F)(F)OC1=CC2=C(C=C1)N=C(S2)N1CCNCC1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Farinato A, et al. Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels. ACS Med Chem Lett. 2023 Jun 23;14(7):999-1008.?
产品手册
关联产品
  • Carbamazepine

    卡马西平是一种钠通道阻滞剂,是一种抗惊厥化合物。

  • Silperisone HCl

    Silperisone HCl (RGH-5002) blocks sodium and calcium channels in cells, decreases excitability and contractility of muscle cells, reduces peripheral tone, and acts as a muscle relaxant and peripheral vasodilator. Silperisone HCl is used to treat recurrent painful myoclonus due to spinal cord injury, abnormal hypertonia due to cerebrovascular disease, dystonia symptoms, cone tension syndrome, multiple sclerosis myospasm and myelitis. silperisone is a sodium channel protein type 2 alpha channel blocker. silperisone is an organosilicon similar to tolperisone, an organosilicon compound with centrally acting muscle relaxant properties.

  • APETx2

    Acid-sensing ion channel 3 (ASIC3) channel blocker (IC50 values are 63 and 175 nM for homomeric rat and human ASIC3 channels). Also inhibits NaV1.8 and NaV1.2 channels (IC50 values are 55 and 114 nM respectively). Demonstrates analgesic properties against acid-induced and inflammatory pain.